Inside Covid-19: Good news on the Oxford vaccine – and enforced changes to spending habits. Ep 63
In Episode 63 of Inside Covid-19, some sage advice for us to cement lower spending habits enforced through the lockdown.
In Episode 63 of Inside Covid-19, some sage advice for us to cement lower spending habits enforced through the lockdown.
The Rand had a good day amid news that Moderna has produced a promising Covid-19 vaccine. It led a rally as the US dollar slumped to a one-month low.
The Dean of the Faculty of Health Sciences at Wits University, Prof Martin Veller, gives a sobering assessment of the timeline for Covid-19 vaccines in South Africa.
South Africa has been given the opportunity to trial the Oxford Covid-19 vaccine. The University of the Witwatersrand started human trials this week.
South Africa is starting Covid-19 vaccine trials and Aspen can manufacture enough dexamethasone to cope with a huge number of Covid-19 cases.
TheĀ South AfricanĀ Ox1Cov-19 Vaccine VIDA-TrialĀ aims to find a vaccine that will prevent infection by SARS-CoV-2, the virus that causes Covid-19.
The news about dexamethasone ā a potential new Covid-19 treatment ā is great, but it doesnāt mean weāre out of the woods. Not by a long shot.
Nearly 1,500 people have died of Covid-19 in South Africa, the government said at the weekend, highlighting that Deputy Minister of Correctional Services Nkosi Phathekile Holomisa has tested positive for coronavirus.
Vaccines are far away and lockdowns are unsustainable. Thus, we will have to rebuild our lives so that we can live alongside Covid-19.
There have been promising early trials of a Covid-19 vaccine, and some for a usable shot by year-end. In reality however, we are in the very early days.